Biogen Inc Stock Performance
| BIIB Stock | USD 196.52 1.02 0.52% |
On a scale of 0 to 100, Biogen holds a performance score of 10. The firm shows a Beta (market volatility) of 0.91, which signifies possible diversification benefits within a given portfolio. Biogen returns are very sensitive to returns on the market. As the market goes up or down, Biogen is expected to follow. Please check Biogen's maximum drawdown, semi variance, and the relationship between the sortino ratio and potential upside , to make a quick decision on whether Biogen's price patterns will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Biogen Inc are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat inconsistent forward indicators, Biogen sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 0.52 | Five Day Return 4.34 | Year To Date Return 10.52 | Ten Year Return (23.39) | All Time Return 6.2 K |
Last Split Factor 3:1 | Last Split Date 2001-01-18 |
1 | Eisai submits Marketing Authorisation Variation to EMA for intravenous maintenance dosing every four weeks with Leqembi | 01/26/2026 |
2 | Acadia Faces EMA Setback On Rett Drug As Regulatory Test Looms | 02/03/2026 |
3 | Biogen stock pops, Robinhood gets lift as bitcoin ticks up | 02/06/2026 |
4 | Disposition of 2660 shares by Singhal Priya of Biogen at 199.83 subject to Rule 16b-3 | 02/09/2026 |
5 | Why Biogen Is Up 8.2 percent After Mixed 2025 Earnings and Neurology Pipeline Updates And Whats Next | 02/10/2026 |
6 | Royalty Pharma Q4 Earnings Call Highlights | 02/11/2026 |
7 | Teako Announces Intention to Apply for Secondary Listing on Frankfurt Stock Exchange and Engages We Are Outliers for Strategic Branding and Marketing | 02/12/2026 |
8 | Wedbush Lifts PT on Biogen Inc. to 187 From 178 Heres Why | 02/13/2026 |
| Begin Period Cash Flow | 2.4 B | |
| Total Cashflows From Investing Activities | -1.4 B |
Biogen Relative Risk vs. Return Landscape
If you would invest 16,793 in Biogen Inc on November 19, 2025 and sell it today you would earn a total of 2,859 from holding Biogen Inc or generate 17.02% return on investment over 90 days. Biogen Inc is currently generating 0.2869% in daily expected returns and assumes 2.2474% risk (volatility on return distribution) over the 90 days horizon. In different words, 20% of stocks are less volatile than Biogen, and 95% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Biogen Target Price Odds to finish over Current Price
The tendency of Biogen Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 196.52 | 90 days | 196.52 | about 1.19 |
Based on a normal probability distribution, the odds of Biogen to move above the current price in 90 days from now is about 1.19 (This Biogen Inc probability density function shows the probability of Biogen Stock to fall within a particular range of prices over 90 days) .
Biogen Price Density |
| Price |
Predictive Modules for Biogen
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Biogen Inc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Biogen Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Biogen is not an exception. The market had few large corrections towards the Biogen's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Biogen Inc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Biogen within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.31 | |
β | Beta against Dow Jones | 0.91 | |
σ | Overall volatility | 8.69 | |
Ir | Information ratio | 0.14 |
Biogen Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Biogen for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Biogen Inc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Over 95.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from insidermonkey.com: Wedbush Lifts PT on Biogen Inc. to 187 From 178 Heres Why |
Biogen Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Biogen Stock often depends not only on the future outlook of the current and potential Biogen's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Biogen's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 146.7 M | |
| Cash And Short Term Investments | 3.8 B |
Biogen Fundamentals Growth
Biogen Stock prices reflect investors' perceptions of the future prospects and financial health of Biogen, and Biogen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biogen Stock performance.
| Return On Equity | 0.0739 | ||||
| Return On Asset | 0.0614 | ||||
| Profit Margin | 0.13 % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 31.6 B | ||||
| Shares Outstanding | 146.76 M | ||||
| Price To Earning | 14.83 X | ||||
| Price To Book | 1.58 X | ||||
| Price To Sales | 2.92 X | ||||
| Revenue | 9.81 B | ||||
| Gross Profit | 7.81 B | ||||
| EBITDA | 3.1 B | ||||
| Net Income | 1.29 B | ||||
| Cash And Equivalents | 4.91 B | ||||
| Cash Per Share | 34.10 X | ||||
| Total Debt | 6.95 B | ||||
| Debt To Equity | 0.52 % | ||||
| Current Ratio | 2.49 X | ||||
| Book Value Per Share | 124.36 X | ||||
| Cash Flow From Operations | 2.2 B | ||||
| Earnings Per Share | 8.78 X | ||||
| Market Capitalization | 28.84 B | ||||
| Total Asset | 29.44 B | ||||
| Retained Earnings | 20.55 B | ||||
| Working Capital | 5.62 B | ||||
| Current Asset | 8.73 B | ||||
| Current Liabilities | 3.42 B | ||||
About Biogen Performance
By analyzing Biogen's fundamental ratios, stakeholders can gain valuable insights into Biogen's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Biogen has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Biogen has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 273.16 | 259.51 | |
| Return On Tangible Assets | 0.09 | 0.08 | |
| Return On Capital Employed | 0.07 | 0.08 | |
| Return On Assets | 0.04 | 0.05 | |
| Return On Equity | 0.07 | 0.10 |
Things to note about Biogen Inc performance evaluation
Checking the ongoing alerts about Biogen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Biogen Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Over 95.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from insidermonkey.com: Wedbush Lifts PT on Biogen Inc. to 187 From 178 Heres Why |
- Analyzing Biogen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biogen's stock is overvalued or undervalued compared to its peers.
- Examining Biogen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Biogen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biogen's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Biogen's stock. These opinions can provide insight into Biogen's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Biogen Stock analysis
When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |